NCT00110448View on ClinicalTrials.gov

Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

2,539

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Coronary DiseaseArteriosclerosisDiabetes Mellitus, Type 2
Interventions
DRUG

Aspirin

Aspirin 81 mg or 100 mg per day

DRUG

No aspirin

No aspirin use

Trial Locations (2)

860-8556

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto

634-8522

First Department of Internal Medicine, Nara Medical University, Kashihara

All Listed Sponsors
lead

Kumamoto University

OTHER

NCT00110448 - Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial | Biotech Hunter | Biotech Hunter